Glucose dysregulation in pre-clinical Alzheimer's disease.
Connolly, Niamh M C; Theurey, Pierre; Pizzo, Paola.
Aging (Albany NY)
; 11(15): 5296-5297, 2019 Aug 04.
Artigo em Inglês | MEDLINE | ID: mdl-31386625
Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer's disease: an early event in disease pathogenesis.
A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.
Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.
'Clinical trials in Alzheimer's disease': immunotherapy approaches.
Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, ß-amyloid toxicity, and astrocyte function.
Synthetic scaffolds help airway cells reach maturity.
Modulation of glucose metabolism and metabolic connectivity by ß-amyloid.
The complexities of behavioural assessment in neurodegenerative disorders: A focus on Alzheimer's disease.
Pre-clinical optical imaging and MRI for drug development in Alzheimer's disease.
Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?